The biowaiver extension for BCS class III drugs: the effect of dissolution rate on the bioequivalence of BCS class III immediate-release drugs predicted by computer simulation.

Source:http://linkedlifedata.com/resource/pubmed/id/20557130

Mol. Pharm. 2010 Aug 2 7 4 1235-43

Download in:

View as

General Info

PMID
20557130